Showing results (381-390 of 743) with videos related to

Sort By:
Pageof 75
American Journal of Hematology|October 28, 2021
Prognostic significance of acquired 1q22 gain in multiple myelomaHadiyah Y Audil, Joselle M Cook, Patricia T Greipp, et al.
Blood Advances|July 27, 2026
Predictors of post-transplant measurable residual disease negativity and impact on clinical outcomes in multiple myelomaAbiola Bolarinwa, Saurabh S Zanwar, Nadine Abdallah, et al.
Experimental Hematology|March 19, 2008
R-(-)-gossypol (AT-101) activates programmed cell death in multiple myeloma cellsMichael P Kline, S Vincent Rajkumar, Michael M Timm, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 8, 2026
The International Myeloma Society Honors the Life and Legacy of Myeloma Pioneer Brian G. M. Durie, MD, PhD (1942-2025)Philippe Moreau, Shaji Kumar, Noopur S Raje, et al.
Expert Opinion on Pharmacotherapy|November 14, 2018
Ixazomib for the treatment of multiple myelomaPaul G Richardson, Sonja Zweegman, Elizabeth K O'Donnell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2007
Relationship between depth of response and outcome in multiple myelomaDavid Dingli, Jorge M Pacheco, Grzegorz S Nowakowski, et al.
Blood|July 26, 2003
Long-term follow-up of IgM monoclonal gammopathy of undetermined significanceRobert A Kyle, Terry M Therneau, S Vincent Rajkumar, et al.
Archives of Dermatology|October 19, 2005
Successful treatment of scleromyxedema with autologous peripheral blood stem cell transplantationMartha Q Lacy, William J Hogan, Morie A Gertz, et al.
Pageof 75